Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ciprofloxacin encapsulated in liposomes has been employed in anti-TB therapy, offering pulmonary delivery through nebulization.
“Ciprofloxacin encapsulated in liposomes has been employed in anti-TB therapy, offering pulmonary delivery through nebulization.”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [207]
Finlay et al. showed high loading efficiency (90%) of liposomes made of phosphatidylcholine and cholesterol, of which up to 30% remained encapsulated after nebulization.
“Finlay et al. showed high loading efficiency (90%) of liposomes made of phosphatidylcholine (PC) and Chol, of which up to 30% remained encapsulated after nebulization.207”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [207]
The best loading efficiency (nearly 100%) was obtained by a negatively charged phospholipid, dimyristoyl phosphatidylglycerol.
“In another investigation by the same authors, the best loading efficiency (nearly 100%) was obtained by a negatively charged phospholipid, dimyristoyl phosphatidylglycerol.207”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [207]
The citation lists haven’t been fetched yet
References 19 · Cited by 51
- Authors
- Finlay, W. H., & Wong, J. P.
- Affiliations
- University of Alberta (CA)
- Defence Research and Development Canada (CA)
- Corresponding author
- Finlay, W.H
- ORCID
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 1998-06
- Volume
- 167
- Issue
- 1-2
- Pages
- 121-127
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2074787984
- Cited by
- 51
- References
- 19
- Citations by year
- 2024: 3 · 2023: 2 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- nebulized aerosol, regional lung deposition, nebulizer comparison, liposome disruption, inhaled aerosols, droplet size distribution, tracheobronchial deposition, alveolar deposition, encapsulation efficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
